🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.
UPGRADE TO SEE LIVE SIGNALS
$RGNX
REGENXBIO Inc
FREE PREVIEW
AVG HISTORICAL GAP-2.07%
MAX GAP RECORD-11.02%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY5.4%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL